Vaccine News and Research

Latest Vaccine News and Research

Monoclonal-antibody combination AZD7442 prevents COVID-19

In a recent study published in The New England Journal of Medicine, the researchers examined the monoclonal-antibody combination AZD7442 to prevent coronavirus disease 2019 (COVID-19).

25 Apr 2022

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

A recent review paper, published in the MDPI’s specialized journal COVID, highlights key features of the Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – and examines the potential and roadblocks in using renewable marine resources in the fight against the coronavirus disease 2019 (COVID-19).

24 Apr 2022

Detection of prior SARS-CoV-2 infection by T-cell receptor sequencing

A new study describes a novel COVID-19 detection technique based on T-cell receptor sequencing.

24 Apr 2022

Quercetin and other plant flavonols show anti-SARS-CoV-2 activity

A new study discusses the potential of certain plant compounds to block SARS-CoV-2 replication within host cells.

24 Apr 2022

Booster vaccine provides similar protection in SARS-CoV-2 naive and convalescent individuals

Researchers estimate the effectiveness of primary vaccination and a booster dose in people with and without prior SARS-CoV-2 infection.

24 Apr 2022

Impact of COVID-19 vaccination on anti-nucleocapsid antibody levels

Anti-N antibodies may have lower sensitivity in mRNA-1273-vaccinated individuals who were previously infected with SARS-CoV-2.

24 Apr 2022

Heterologous booster dose leads to better SARS-CoV-2 vaccine performance, study shows

A new study on Chile's national COVID-19 vaccination program, to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon 23-26), and published in The Lancet Global Health, shows that giving a different type of vaccine (heterologous) for the third or 'booster' dose than was received for the first two doses, leads to better vaccine performance than using the same (homologous) inactivated SARS-CoV-2 vaccine for all three doses.

24 Apr 2022

Study: A considerable number of healthcare workers took sick leave after COVID-19 vaccination

A third of healthcare workers took sick leave after being vaccinated against COVID-19, a German study presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April) has found.

23 Apr 2022

COVID-19 vaccine protection against omicron wanes over time, study shows

A study released April 22 in The Lancet Respiratory Medicine shows that a booster dose of the Pfizer COVID-19 vaccine provides strong protection, roughly 80% to 90%, in the first few months against hospital admissions and emergency department visits caused by the delta and omicron variants. However, against omicron, this protection wanes over time - even after a third dose.

23 Apr 2022

COVID-19 revealed disparities in how the virus impacted people of color, New York State Health Commissioner says

The COVID-19 pandemic revealed vast disparities in how the virus impacted people of color, with inequalities in exposure and treatment that persist two years later, said New York State Health Commissioner Dr. Mary Bassett in her Population Health Sciences Grand Rounds address, hosted virtually on April 20 by Weill Cornell Medicine.

22 Apr 2022

Study demonstrates increased incidence of SARS-CoV-2 Omicron breakthrough infection in cancer patients

Scientists have demonstrated the incidence of SARS-CoV-2 infection in cancer patients residing in Austria and Italy.

22 Apr 2022

Incidence of venous thromboembolism following COVID-19 vaccination

Researchers investigated the association between genetic predisposition to venous thromboembolism and increased risk of thrombosis post-COVID-19 vaccination.

22 Apr 2022

Efficacy of vaccination against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages in Sweden

Researchers compared the vaccine effectiveness against infections by SARS-CoV-2 variant of concern Omicron BA.1 and BA.2 sublineages in Sweden.

22 Apr 2022

Antibody escape in SARS-CoV-2 Omicron spike protein

Researchers examined antibody escape and cross-domain stabilization in the SARS-CoV-2 Omicron spike protein.

22 Apr 2022

Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious

Researchers compared the efficiency of monovalent and bivalent mRNA vaccines against SARS-CoV-2.

22 Apr 2022

Booster dose of BNT162b2 mRNA vaccine induces a high cross-neutralizing response against SARS-CoV-2 variants

Researchers assessed the impact of SARS-CoV-2 mRNA booster vaccine on the SARS-CoV-2 Omicron variant.

22 Apr 2022

COVID-19 mRNA vaccine protects against ICU admission for 1 year

Researchers investigate the duration of effectiveness of mRNA-based COVID-19 vaccines in preventing ICU admission.

21 Apr 2022

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

Researchers isolate three mAbs that broadly neutralized sarbecoviruses and carried out virological and structural studies of these mAbs.

21 Apr 2022

Hybrid alphavirus-SARS-CoV-2 pseudovirus system rapidly measures neutralizing antibodies

Do a person's antibodies work to block the COVID-19 virus from infecting one's system? Are these antibodies also capable of blocking emerging variants such as the omicrons?

21 Apr 2022

Texas A&M AgriLife scientists receive grant to fight pesticide-resistant cattle fever ticks

Two projects by Texas A&M AgriLife Research scientists aim to protect the U.S. cattle industry from the emerging threat of pesticide-resistant cattle fever ticks.

21 Apr 2022

Vaccine News and Research

Latest Vaccine News and Research

Monoclonal-antibody combination AZD7442 prevents COVID-19

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

Detection of prior SARS-CoV-2 infection by T-cell receptor sequencing

Quercetin and other plant flavonols show anti-SARS-CoV-2 activity

Booster vaccine provides similar protection in SARS-CoV-2 naive and convalescent individuals

Impact of COVID-19 vaccination on anti-nucleocapsid antibody levels

Heterologous booster dose leads to better SARS-CoV-2 vaccine performance, study shows

Study: A considerable number of healthcare workers took sick leave after COVID-19 vaccination

COVID-19 vaccine protection against omicron wanes over time, study shows

COVID-19 revealed disparities in how the virus impacted people of color, New York State Health Commissioner says

Study demonstrates increased incidence of SARS-CoV-2 Omicron breakthrough infection in cancer patients

Incidence of venous thromboembolism following COVID-19 vaccination

Efficacy of vaccination against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages in Sweden

Antibody escape in SARS-CoV-2 Omicron spike protein

Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious

Booster dose of BNT162b2 mRNA vaccine induces a high cross-neutralizing response against SARS-CoV-2 variants

COVID-19 mRNA vaccine protects against ICU admission for 1 year

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

Hybrid alphavirus-SARS-CoV-2 pseudovirus system rapidly measures neutralizing antibodies

Texas A&M AgriLife scientists receive grant to fight pesticide-resistant cattle fever ticks

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in